showed that pentanoate and butyrate enhance the anti-tumor activity of human and murine cytotoxic T lymphocytes (CTLs) and CAR T cells that recognize receptor tyrosine kinase-like orphan receptor 1 (ROR1), through metabolic and epigenetic reprogramming. Here, ROR1 is linked to neoplasm.